Question 1

What is the catalog number for Anti-PEBP4 Antibody?

Accepted Answer

The catalog number for Anti-PEBP4 Antibody is MBS8323579.

Question 2

What sizes are available for Anti-PEBP4 Antibody?

Accepted Answer

Anti-PEBP4 Antibody is available in the following size(s): 0.03 mL, 0.05 mL, 0.1 mL, 0.2 mL, 5x 0.2 mL.

Question 3

How many pack sizes does Anti-PEBP4 Antibody come in?

Accepted Answer

Anti-PEBP4 Antibody is available in 5 different pack sizes.

Question 4

Is Anti-PEBP4 Antibody in stock?

Accepted Answer

Anti-PEBP4 Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Anti-PEBP4 Antibody

Product Specifications

Gene Name

NCBI Gene ID

Reactivity

Storage Conditions

Specificity

Other Gene Names

Short Name

Other Product Names

NCBI GI Number

NCBI Accession Number

NCBI GB Accession Number

Uniprot Accession Number

Available Sizes

Frequently Asked Questions

Explore Other Products

SLC7A7 (NM_001126106) Human Over-expression Lysate

Quercetin 3-O-Beta-D-Glucuronide

Cytokeratin 8/18 (KRT8/803 + KRT18/835), CF405S conjugate, 0.1mg/mL

CellBrite® Steady 650 Membrane Staining Kit, 100 Labelings

HINT1 (NM_005340) Human Recombinant Protein

Elab Fluor® 700 Anti-Human CD41 Antibody[HIP8]